Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial

British Journal of Radiology

Volumn 85, Issue 1017, 2012, Pages

  Tsang, Yat ^a   Venables, K ^a   Yarnold, J ^b  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; COLLIMATOR; HEALTH CENTER; HISTOGRAM; HUMAN; HYPOFRACTIONATION; MAJOR CLINICAL STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDIZATION; TREATMENT PLANNING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84866080625     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/32249628     Document Type: Article

References (34)

1. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75:9-17.
2. Owen JR, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006;7:467-71.
3. START Trialists' Group. The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-41.
4. The START Trialists' Group. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371:1098-107.
5. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-20.
6. Yarnold JR. Early and locally advanced breast cancer: diagnosis and treatment national institute for health and clinical excellence guideline 2009. Clin Oncol (R Coll Radiol) 2009;21:159-60.
7. Bolla M, Bartelink H, Garavaglia G, Gonzalez D, Horiot JC, Johansson KA. EORTC guidelines for writing protocols for clinical trials of radiotherapy. Radiother Oncol 1995;36:1-8.
8. Horiot JC, Van der Schueren E, Johansson KA, Bernier J, Bartelink H. The programme of quality assurance of the EORTC radiotherapy group. A historical overview. Radiother Oncol 1993;29:81-4.
9. Aird EG, William C, Mott GT, Dische S, Saunders MI. Quality assurance in the CHART clinical trial. Radiother Oncol 1995;36:235-44.
10. Venables K, Winfield E, Deighton A, Aird E, Hoskin P. A survey of radiotherapy quality control practice in the United Kingdom for the START trial. Radiother Oncol 2001;60:311-18.
11. Haviland J, Ashton A, Broad B, Gothard L, Owen JR, Tait D, et al. Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancer. Clin Oncol (R Coll Radiol) 2008;20:497-501.
12. START - standardisation of breast radiotherapy, trial protocol. Sutton: Institute of Cancer Research, ICR-CTSU; 1998.
13. International Commission on Radiation Units and Measurements (ICRU). ICRU Report 50: Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: ICRU; 1999.
14. International Commission on Radiation Units and Measurements (ICRU). ICRU Report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). Bethesda, MD: ICRU; 1999.
15. Wilks RJ, Bliss P. The use of a compensator library to reduce dose inhomogeneity in tangential radiotherapy of the breast. Radiother Oncol 2002;62:147-57.
16. Hong L, Hunt M, Chui C, Spirou S, Forster K, Lee H, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 1999;44:1155-64.
17. Kestin LL, Sharpe MB, Frazier RC, Vicini FA, Yan D, Matter RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 2000;48:1559-68.
18. Zackrisson B, Arevarn M, Karlsson M. Optimized MLC beam arrangements for tangential breast irradiation. Radiother Oncol 2000;54:209-12.
19. Evans PM, Donovan EM, Partridge M, Childs PJ, Convery DJ, Eagle S, et al. The delivery of intensity modulated radiotherapy to the breast using multiple static fields. Radiother Oncol 2000;57:79-89.
20. Donovan EM, Johnson U, Shentall GS, Evans PM, Neal AJ, Yarnold JR. Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields. Int J Radiat Oncol Biol Phys 2000;46:671-9.
21. Donovan EM, Bleackley NJ, Evans PM, Reise SF, Yarnold JR. Dose-position and dose volume histogram analysis of standard wedged and intensity modulated treatments in breast radiotherapy. Br J Radiol 2002;75:967-73.
22. Lo YC, Yasuda G, Fitzgerald TJ, Urie MMl. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys 2000;46:187-94.
23. Barnett G, Wilkinson J, Moody A, Wilson CB, Sharma R, Klager S, et al. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 2009;92:34-41.
24. Winfield EA, Deighton A, Venables K, Hoskin PJ, Aird EG. Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance program for the start trial in early breast cancer. Br J Radiol 2003;76:254-9.
25. Evans P, Donovan E, Fenton N, Hansen VN, Moore I, Partridge M, et al. Practical Implementation of compensators in breast radiotherapy. Radiother Oncol 1998;49:255-65.
26. Borger JH, Kemperman H, Smitt HS, Hart A, Van Dongen J, Lebesque J, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 1994;30:1073-81.
27. Jones B, Dale RG, Finst P, Khaksar SJ. Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1379-84.
28. Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 years' follow-up. Radiother Oncol 1989;15:169-88.
29. Fowler J. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
30. Yarnold J, Bentzen SM, Coles C, Haviland J. Hypofractioned whole breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011;79:1-9.
31. Ibbott G, Followill D, Molineu H, Lowenstein JR, Alvarez PE, Roll JE. Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials. Int J Radiat Oncol Biol Phys 2008;71(1 Suppl):S71-5.
32. IMRT Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
33. Das IJ, Cheng C-W, Chopra KL, Mitra RK, Srivastava SP, Glatstein E. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst 2008;100:300-7.
34. James H, Beavis A, Budgell G, Clark C, Convery D, Mott J, et al, eds. IPEM Report 96: Guidance for the clinical implementation of intensity modulated radiation therapy. York: Institute Of Physics and Engineering In Medicine; 2008.